In 18 years, PEDIARIX has never had a supply shortage.1,2 Other manufacturers had primary series DTaP or pediatric HepB vaccine shortages that lasted a year or more.3,*
- GSK distributed millions of additional doses to cover for 3 DTaP-containing vaccine shortages and the global pediatric HepB shortage to help reduce negative impact2
- Shortages ranged from approximately 365 days to 940 days3,4
GSK is the single manufacturer of all the antigens in PEDIARIX. GSK has a consistent DTaP vaccine supply record over the last 18 years, giving you the confidence of supply reliability.1,2,5
- A single antigen source helps to ensure integration of antigen supply and flexibility to respond to your DTaP vaccine needs
DTaP=diphtheria, tetanus, and acellular pertussis; HepB=hepatitis B.
*Data as of August 2020. Shortages of vaccines were identified by the Center for Biologics Evaluation and Research (CBER) within the Food and Drug Administration. CBER works closely with the manufacturer to voluntarily obtain accurate information.